Zentalis Pharmaceuticals
ZNTL
#8783
Rank
NZ$0.26 B
Marketcap
NZ$4.14
Share price
0.82%
Change (1 day)
7.21%
Change (1 year)

Earnings for Zentalis Pharmaceuticals (ZNTL)

Earnings in 2025 (TTM): -NZ$0.26 Billion

According to Zentalis Pharmaceuticals's latest financial reports the company's current earnings are NZ$26.86 Million. In 2024 the company made an earning of -NZ$0.28 Billion, an increase over its 2023 earnings that were of -NZ$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zentalis Pharmaceuticals from 2019 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.26 Billion-6.4%
2024 -NZ$0.28 Billion-40.16%
2023 -NZ$0.47 Billion25.12%
2022 -NZ$0.38 Billion34.48%
2021 -NZ$0.28 Billion39.33%
2020 -NZ$0.2 Billion154.74%
2019 -NZ$77.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.27 Billion 6.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.42 Million-87.86%๐Ÿ‡บ๐Ÿ‡ธ USA